Akanda Total Liabilities and Share Holders Equity 2021-2024 | AKAN
Akanda total liabilities and share holders equity from 2021 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
| Akanda Annual Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2023 | $9 |
| 2022 | $39 |
| 2021 | $8 |
| 2020 | $4 |
| Akanda Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2023-12-31 | $9 |
| 2023-06-30 | $37 |
| 2022-12-31 | $39 |
| 2022-06-30 | $43 |
| 2021-12-31 | $8 |
| 2020-12-31 | $4 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.002B | $0.001B |
| Akanda Corp. provides medical cannabis and wellness platform. The company's initial portfolio includes Bophelo Bioscience & Wellness, a GACP qualified cultivation campus in the Kingdom of Lesotho in Southern Africa and CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK. Akanda Corp. is based in LONDON. | |||